NIDA Avant-Garde/Avenir awards for high-risk HIV and substance use research (ESI eligible)
NIDA plans to release a NOFO for Avant-Garde/Avenir awards supporting pioneering, high-risk/high-reward research on HIV in the context of substance use and SUDs, including early stage investigators. This DP1 program seeks transformative biomedical and behavioral approaches. Applications are not being accepted yet; this notice is to help researchers prepare collaborations and projects.
The National Institue on Drug Abuse (NIDA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on pioneering research in HIV and Substance use/substance use disorder (SUD) research. The Avant-Garde Award Program is designed to support exceptionall…
Funding Source
Eligibility
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers